Search Results - "Chalus, Lionel"

Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer by Alzeeb, George, Tortorelli, Corinne, Taleb, Jaqueline, De Luca, Fanny, Berge, Benoit, Bardet, Chloé, Limagne, Emeric, Brun, Marion, Chalus, Lionel, Pinteur, Benoit, Bravetti, Paul, Gongora, Céline, Apetoh, Lionel, Ghiringhelli, Francois

“…Colorectal cancer (CRC) remains a significant global health burden, emphasizing the need for innovative treatment strategies. 95% of the CRC population are…”
Get full text

1132 Stimulated tumor cells (STC) vaccine induce response in colorectal cancer by Alzeeb, George, Chalus, Lionel, Bessede, Alban, Wang, Yan, Peyronnier, Arnaud, Tortorelli, Corinne, Pinteur, Benoit, Bravetti, Paul, Italiano, Antoine

“…BackgroundColorectal cancer (CRC) is the second leading cause of cancer-related death in the world and often detected at late stages (38% of metastasis cases…”
Get full text

FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells by Fournier, Nathalie, Chalus, Lionel, Durand, Isabelle, Garcia, Eric, Pin, Jean-Jacques, Churakova, Tatyana, Patel, Segal, Zlot, Constance, Gorman, Dan, Zurawski, Sandra, Abrams, John, Bates, Elizabeth E. M, Garrone, Pierre

“…In this study, we describe human FDF03, a novel member of the Ig superfamily expressed as a monomeric 44-kDa transmembrane glycoprotein and containing a single…”
Get full text

Efficacy of STC-1010, a new allogenic cancer vaccine in colorectal cancer models by You, Benoit, Tortorelli, Corinne, Wang, Yan, Peyronnier, Arnaud, Bessede, Alban, Gongora, Céline, Pinteur, Benoit, Chalus, Lionel, Alzeeb, George, Bravetti, Paul, Ghiringhelli, François

“…e14661 Background: Colorectal cancer (CRC) is the second cause of cancer-related death worldwide. Recent tremendous progresses have installed immunotherapy as…”
Get full text

BreAK CRC, a first-in-human phase I/II trial of STC-1010, a new allogenic cancer vaccine for advanced or metastatic unresectable colorectal cancer by You, Benoit, Italiano, Antoine, Hollebecque, Antoine, Awada, Ahmad, Sclafani, Francesco, Tosi, Diego, Cassier, Philippe Alexandre, Christenson, Eric, Tougeron, David, Pérol, David, Tortorelli, Corinne, Pinteur, Benoit, Chalus, Lionel, Alzeeb, George, Bravetti, Paul, Ghiringhelli, François

“…TPS3635 Background: Colorectal cancer (CRC) is the 3rd most common cancer worldwide. Although immunotherapy was found active in dMMR/MSI-H “hot” CRC, there is…”
Get full text

Abstract 3566: Sensitizing potential of a novel stimulated and haptenized vaccine in immunotherapy resistant metastatic colorectal cancer by Richard, Corentin, Chevrier, Sandy, Chalus, Lionel, Forget, Jeremy, Pinteur, Benoît, Bravetti, Paul, Boidot, Romain

“…Abstract BACKGROUND: Colorectal cancer (CRC) is the second most common solid organ cancer. Immunotherapy has recently emerged as a promising treatment for the…”
Get full text

Abstract LB224: STC-1010 a new therapeutic vaccine promotes tumor cell death by Bessede, Alban, Alzeeb, George, Tortorelli, Corinne, Guegan, Jean-Philippe, Rey, Christophe, Chalus, Lionel, Pinteur, Benoit, Bravetti, Paul, Italiano, Antoine

“…Abstract BACKGROUND Colorectal cancer (CRC) is the third most commonly diagnosed cancer (10% of new cases in 2020) and the second leading cause of…”
Get full text

Abstract 6791: Inovative in vivo (i n ovo ) CAM model to predict efficacy and mode of action of a new antitumor vaccine stc-1010 on human colorectal adenocarcinoma by Wang, Yan, Peyronnier, Arnaud, Pinteur, Benoit, Chalus, Lionel, Tortorelli, Corinne, Bravetti, Paul, Viallet, Jean, Ghiringhelli, François, Fornies, Philippe

“…Abstract BACKGROUND: Colorectal cancer (CRC) is the second-most deadly cancer. Therapeutic resistance to immuno-oncology drives the need for new treatments…”
Get full text

Abstract 5003: Efficacy of the STC-1010 a new allogenic cancer vaccine in different colorectal cancer models by Alzeeb, George, Gongora, Céline, Richard, Corentin, Boidot, Romain, Fortin, Tanguy, Wang, Yan, Bessede, Alban, Pinteur, Benoit, Chalus, Lionel, Tortorelli, Corinne, Bravetti, Paul, Ghiringhelli, François

“…Abstract Colorectal cancer (CRC) is the 2nd cause of cancer-related death worldwide. Recent tremendous progress has installed immunotherapy as a treatment…”
Get full text

1179 Efficacy study of STC-1010 antitumor vaccine associated with standard chemotherapies on MC 38 syngeneic colon cancer tumor model by Tortorelli, Corinne, Gongora, Celine, Mathe, Doriane, Pinteur, Benoit, Chalus, Lionel, Bravetti, Paul, Gadot, Nicolas, Lantuejoul, Sylvie, Dumontet, Charles, Ghiringhelli, François

“…BackgroundMetastatic colorectal cancer(mCRC) is a major cause of death. Unmet medical need in immunotherapy is high for MSS patients and still present for…”
Get full text

Abstract 2051: Antitumor activity of a novel allogeneic colorectal cancer vaccine in C57BL/6 mice bearing MC38 anti-PD1 resistant colon carcinoma syngeneic model with TME by Gongora, Céline, Kress, Elsa, Vermot-Desroches, Claudine, Chalus, Lionel, Forget, Jeremy, Pinteur, Benoît, Bravetti, Paul, Dumontet, Charles, Italiano, Antoîne

“…Abstract BACKGROUND: Metastatic colorectal cancer (mCRC) is one of the major causes of death worldwide. The relative therapeutic resistance of these…”
Get full text